Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1779)	5/3/2007 12:18:53 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

BLSI Is up 9% after announcing that it has issued a convertible promissory note to the investment fund managed by Highbridge for $6M. finance.yahoo.com bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (1779)	1/16/2008 11:03:05 AM
From: Jibacoa	Respond to of 3722

AMRI seems to have found support at the $12.40 level & is trying again to go over $14. It is up 8% on moderate volume of 33Ks. bigcharts.marketwatch.com AMRI redesigned its website with the purpose of improving its image as a provider of high quality, cost-effective drug discovery, development and manufacturing services throughout the world, according to its CEO, Thomas E. D'Ambra, Ph.D. It has 4Qs of double digit improvements on revenues & earnings.It trades around 1.33xBV with a +CF around $0.60 The short ratio came down 10% last month & is around 11x its ADV The stock has substantial resistance at the $17 & $19 levels. It needs to close above that in order to get off from the DT coming from its Dec2000 H at $71 <g> bigcharts.marketwatch.com Bernard